BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 2026875)

  • 1. IL-6 and tumor necrosis factor-alpha. Autocrine and paracrine cytokines involved in B cell function.
    Rieckmann P; D'Alessandro F; Nordan RP; Fauci AS; Kehrl JH
    J Immunol; 1991 May; 146(10):3462-8. PubMed ID: 2026875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four cell-secreted cytokines act synergistically to maintain long term proliferation of human B cell lines in vitro.
    Abken H; Fluck J; Willecke K
    J Immunol; 1992 Oct; 149(8):2785-94. PubMed ID: 1328386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV induces IL-6 production by human B lymphocytes. Role of IL-4.
    Boue F; Wallon C; Goujard C; Barre-Sinoussi F; Galanaud P; Delfraissy JF
    J Immunol; 1992 Jun; 148(12):3761-7. PubMed ID: 1376339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytokines in children with immunodeficiencies].
    Kowalczyk D
    Folia Med Cracov; 1999; 40(1-2):5-97. PubMed ID: 10909468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-8 differentially modulates interleukin-4- and interleukin-2-induced human B cell growth.
    Kimata H; Lindley I
    Eur J Immunol; 1994 Dec; 24(12):3237-40. PubMed ID: 7805753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes.
    Kehrl JH; Roberts AB; Wakefield LM; Jakowlew S; Sporn MB; Fauci AS
    J Immunol; 1986 Dec; 137(12):3855-60. PubMed ID: 2878044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of eleven cytokines and of IL-1 and tumor necrosis factor inhibitors in a human B cell assay.
    Tucci A; James H; Chicheportiche R; Bonnefoy JY; Dayer JM; Zubler RH
    J Immunol; 1992 May; 148(9):2778-84. PubMed ID: 1315359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-2 enhances the production of tumor necrosis factor-alpha in activated B-type chronic lymphocytic leukemia (B-CLL) cells.
    Larsson LG; Carlsson M; Schena M; Lantz M; Caligaris-Cappio F; Nilsson K
    Leukemia; 1993 Feb; 7(2):226-34. PubMed ID: 8381194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of inhibitory activity for B cell differentiation in human CD8 T cells with pokeweed mitogen, dimaprit, and cAMP upregulating agents: countersuppressive effect of platelet factor 4.
    Crisi GM; Katz IR; Zucker MB; Thorbecke GJ
    Cell Immunol; 1996 Sep; 172(2):205-16. PubMed ID: 8964082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-alpha and interleukin 1.
    Jelinek DF; Lipsky PE
    J Immunol; 1987 Nov; 139(9):2970-6. PubMed ID: 3117883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
    Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
    J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory role of IL-4 on the secretion of Ig by human B cells.
    Splawski JB; Jelinek DF; Lipsky PE
    J Immunol; 1989 Mar; 142(5):1569-75. PubMed ID: 2493049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyclonal B-cell activation by an arthritogenic Staphylococcus aureus strain: contribution of T-cells and monokines.
    Abdelnour A; Tarkowski A
    Cell Immunol; 1993 Apr; 147(2):279-93. PubMed ID: 8453672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of urokinase-type plasminogen activator gene expression by inflammatory cytokines in human pre-B lymphoma cell line RC-K8.
    Niiya K; Shinbo M; Ozawa T; Hayakawa Y; Sakuragawa N
    Thromb Haemost; 1995 Dec; 74(6):1511-5. PubMed ID: 8772229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA.
    Kehrl JH; Thevenin C; Rieckmann P; Fauci AS
    J Immunol; 1991 Jun; 146(11):4016-23. PubMed ID: 1903417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of Staphylococcus aureus exotoxin A inhibition of Ig production by human B cells.
    Moseley AB; Huston DP
    J Immunol; 1991 Feb; 146(3):826-32. PubMed ID: 1988499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine network regulating terminal maturation of human bone marrow B cells capable of spontaneous and high rate Ig secretion in vitro.
    Roldán E; Rodriguez C; Navas G; Parra C; Brieva JA
    J Immunol; 1992 Oct; 149(7):2367-71. PubMed ID: 1527383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression.
    Wu S; Boyer CM; Whitaker RS; Berchuck A; Wiener JR; Weinberg JB; Bast RC
    Cancer Res; 1993 Apr; 53(8):1939-44. PubMed ID: 8385577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody against the human peripheral lymph node homing receptor homologue (Leu 8) inhibits B cell differentiation but not B cell proliferation.
    Murakawa Y; Strober W; James SP
    J Immunol; 1991 Jan; 146(1):40-6. PubMed ID: 1701799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of lymphokines mediating B cell growth and differentiation from monoclonal anti-CD3 antibody-stimulated T cells.
    Sherris D; Stohl W; Mayer L
    J Immunol; 1989 Apr; 142(7):2343-51. PubMed ID: 2538506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.